Monitoring ovarian reserve dynamics via a high-sensitivity anti-M&#xfc;llerian hormone assay in premenopausal breast cancer patients undergoing chemotherapy

Uro-Oncology

Influence of Adverse Pathologic Features on Potential Benefit of Hormone Therapy Use with Postoperative Radiotherapy in Recurrent Prostate Cancer: An Individual Patient Data Meta-analysis

Eur Urol

Kishan AU, Sun Y, Parker CC, Sargos P, Sydes M, Chabaud S, Brihoum M, Supiot S, Latorzeff I, Guerif S, Kalbasi TR, Steinberg ML, Valle LF, Taparra K, Farrell MJ, Shoag JE, Garcia JA, Brown JR, Rettig MB, Singer AE, Baclig N, Reiter RE, Eggener S, Brisbane W, Roy S, Jia AY, Ma TM, Nickols NG, Efstathiou JA, Dignam JJ, Seiferheld WF, Pollack A, Sandler HM, Nguyen PL, Pommier P, Spratt DE

doi: 10.1016/j.eururo.2026.07.013

Uro-OncologyMenopause

Management of surgical menopause in female patients with bladder cancer undergoing radical cystectomy

Nat Rev Urol

Day E, Bizzarri FP, Mackenzie C, Szabados B, Nelson AW, Colquhoun AJ, Perry MJ, Kelly JD, Lobo N

doi: 10.1038/s41585-026-01124-z

Further Publications Gynecology

A randomized controlled trial comparing remote blood pressure monitoring with office-based blood pressure monitoring for women at high risk of preeclampsia

Am J Obstet Gynecol

Rajkumar T, Hennessy A, Shanmugalingam R, You W, Canty A, Pickup W, Potter D, Butten K, Varnfield M, Makris A

doi: 10.1016/j.ajog.2026.04.025

Erectile and Sexual Functions and Dysfunctions

Long-term predictors of assisted erectile function after high-flow priapism: patient profile matters more than embolization technique

J Sex Med

Basadonna LM, Passarelli F, Rizzo M, Biasatti A, Rossin G, Gadda F, Ciamarra F, Gentile G, Franceschelli A, Preto M, Falcone M, Gontero P, Caviglia A, Manfredi C, Colombo F, Liguori G, Galfano A, Montanari E, Boeri L

doi: 10.1093/jsxmed/qdaf299

HPV and Gynecologic CancerReproductive Health

Fertility-Sparing Treatments in Patient With Gynecologic Cancers

Obstet Gynecol

Erden M, Rehman S, Oh C, Schwartz BM, Kho RM

doi: 10.1097/AOG.0000000000006141

Uro-Oncology

Patient-reported outcomes: active surveillance vs radical therapies in low-risk prostate cancer

BJU Int

Al-Nader M, Kesch C, Mahmoud O, Hadaschik BA, Fichtner J, Carl G, Feick G, Burchardt M, Zimmermanns V, Prause L, Polat B, Blana A, Horstmann M, Saar M, Miglierini P, Almansur K, Hefermehl L, Porres D, Peters I, Wiens K, Palisaar RJ, Winter A, Neisius A, Kunzmann EM, Harke NN, Bolenz C, Albarghouth MH, Manka L, Kramer M, Luger F, Knoll T, Pfitzenmaier J, Brock M, Schittko J, Sommer JP, Reichert M, Lenart S, Huber P, Hijazi S, Calderaro A, Hermanns T, Tonhauser J, Kowalski C, Sibert NT

doi: 10.1111/bju.70167

Further Publications Urology

Ten-Year Clinical Outcomes and Cause of Death in Patients on Dialysis Undergoing Percutaneous Coronary Intervention: A Retrospective Mayo Clinic PCI Registry Analysis

Mayo Clin Proc

Nagaraja V, Lewis BR, Korsapati H, Mene-Afejuku TO, Dillon JJ, Cheungpasitporn W, Gharacholou M, Reeder G, Hibbert B, Best P, Prasad A, Singh M

doi: 10.1016/j.mayocp.2025.11.016

Erectile and Sexual Functions and Dysfunctions

Sexual function in chronic illness and cancer perspectives of the patient, partner, and healthcare provider; innovations; and updates: recommendations from the Fifth International Consultation on Sexual Medicine (ICSM 2024)

Sex Med Rev

Wylie KR, Kirby MG, Nimbi FM, Krychman M, Reese JB, Marshall DC

doi: 10.1093/sxmrev/qeag002

Further Publications Urology

Impact of operative time on complications after PCNL in the elderly (aged ≥70 years): the Safety and Efficacy of Nephrolithotomy in Older patients undergoing PCNL (SENIOR-PCNL) study

BJU Int

Nowak Ł, Krajewski W, Somani B, Szydełko T, Gauhar V, Yuen SKK, Boeykens M, Tailly T, Mykoniatis I, Sierra A, Sener ET, Coninck V, Ergul RB, Olivero A, Tzelves L, Esperto F, Peteinaris A, Yuminaga Y, Hou Q, Juliebø-Jones P, Tsaturyan A, Małkiewicz B, Góral A, Biesiadecka P, Lopez Vivo FJ, Gupta M, Serna J, Savin Z, Anastasiadis A, Memmos D, Slots C, Pages R, Ozdemiroglu C, Frascheri MF, Moreno RC, Ventimiglia E, Kallidonis P, Liatsikos E, Durutovic O, Pietropaolo A, Ballesta Martinez B, YAU Working Group Endourology & Urolithiasis and the EAU Endourology Section

doi: 10.1111/bju.70440

Gynecology · Urology

Monitoring ovarian reserve dynamics via a high-sensitivity anti-Müllerian hormone assay in premenopausal breast cancer patients undergoing chemotherapy

Related content

Influence of Adverse Pathologic Features on Potential Benefit of Hormone Therapy Use with Postoperative Radiotherapy in Recurrent Prostate Cancer: An Individual Patient Data Meta-analysis

Management of surgical menopause in female patients with bladder cancer undergoing radical cystectomy

A randomized controlled trial comparing remote blood pressure monitoring with office-based blood pressure monitoring for women at high risk of preeclampsia

Long-term predictors of assisted erectile function after high-flow priapism: patient profile matters more than embolization technique

Fertility-Sparing Treatments in Patient With Gynecologic Cancers

Patient-reported outcomes: active surveillance vs radical therapies in low-risk prostate cancer

Ten-Year Clinical Outcomes and Cause of Death in Patients on Dialysis Undergoing Percutaneous Coronary Intervention: A Retrospective Mayo Clinic PCI Registry Analysis

Sexual function in chronic illness and cancer perspectives of the patient, partner, and healthcare provider; innovations; and updates: recommendations from the Fifth International Consultation on Sexual Medicine (ICSM 2024)

Impact of operative time on complications after PCNL in the elderly (aged ≥70 years): the Safety and Efficacy of Nephrolithotomy in Older patients undergoing PCNL (SENIOR-PCNL) study